English
This article is from Journal of Advanced Pharmaceutical Technology & Research , volume 2 . Abstract In this work we devised a method to create smaller eye drops of the glaucoma medication timolol maleate by altering the dropper tip design and changing the physical properties of the formulation. Most ocular diseases are treated with topical application of eye drops. After instillation of an eye drop, typically, less than 5% of the applied drug penetrates the cornea and reaches the intraocular tissues; the major fraction of the instilled drug is absorbed and enters the systemic circulation. Ophthalmic solutions are available in multidose or single-dose glass/plastic dropper bottles that deliver drops with a volume that ranges from 25 μL to 70 μL (average 40 μL). Because of the low capacity of the precorneal area, the optimal drop volume is about 20 μL; with larger volumes there is the risk of adverse systemic effects due to absorption of the drug via the nasal mucosa. Thus, both from the biopharmaceutical and economic point of view, drops of only 5-15 mL volume should be instilled into the eye. In this present work we devised a method to reduce the size of the drop by inserting a gla
Sign in with your free account to read, download EPUBs or listen.
Ebook · Reduction in drop size of ophthalmic topical drop preparations and the impact of treatment. · Kumar, Shiva, Karki, Roopa, Meena, Marreddy, Prakash, Tigari, Rajeswari, Tanniru, Goli, Divakar · Internet Archive